DEF 14AThe Ballot
Avalo Therapeutics, Inc. files DEF 14A
Filed Apr 5, 2018 · 8y ago · Accession 0001628280-18-004024
Plain English
Proxy statement — executive pay, board nominees, and shareholder votes.
Read the source below for the full document.
Filing details
- Company
- Avalo Therapeutics, Inc.
- Ticker
- AVTX
- CIK
- 1534120
- Form type
- DEF 14A
- Filing date
- Apr 5, 2018
- Report date
- May 15, 2018
- Document
- cercdef14a-2018.htm
- Size
- 2.0 MB